Get the Stockscreener App
1.10
6.80%
0.07
After Hours:
1.06
-0.04
-3.64%
Bluejay Diagnostics Inc stock is traded at $1.10, with a volume of 354.47K.
It is up +6.80% in the last 24 hours and down -62.46% over the past month.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
See More
Previous Close:
$1.03
Open:
$1.05
24h Volume:
354.47K
Relative Volume:
0.09
Market Cap:
$1.14M
Revenue:
-
Net Income/Loss:
$-6.90M
P/E Ratio:
-0.0785
EPS:
-14.0152
Net Cash Flow:
$-6.65M
1W Performance:
-9.09%
1M Performance:
-62.46%
6M Performance:
-63.80%
1Y Performance:
-82.37%
1-Day Range:
$1.02
$1.11
1-Week Range:
$1.02
$1.17
52-Week Range:
$1.02
$16.68
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Name
Bluejay Diagnostics Inc
Sector
Industry
Phone
(978) 631-0152
Address
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Compare BJDX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
1.10 | 1.07M | 0 | -6.90M | -6.65M | -14.02 |
ABT
Abbott Laboratories
|
104.49 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
336.74 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
84.22 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
45.51 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.04 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bluejay Diagnostics Inc Stock (BJDX) Latest News
BJDX|Bluejay Diagnostics Inc|Price:1.030|Chg%:-0.110 - TradingKey
Bluejay Diagnostics Inc (BJDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bluejay Diagnostics Inc (BJDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bluejay Diagnostics Inc (BJDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Bluejay Diagnostics Inc (BJDX) Income Statement - TradingKey
Bluejay Diagnostics, Inc. Revenue Breakdown – NASDAQ:BJDX - TradingView
Bluejay Diagnostics Inc (BJDX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bluejay Diagnostics initial beneficial ownership statement names Bank of America as 10% owner - Bitget
Bluejay Diagnostics Completes Enrollment in SYMON-II Sepsis Study - TipRanks
Form 4 Bluejay Diagnostics Inc For: 22 July By Investing.com - Investing.com Canada
Bank of America drops below 10% stake in Bluejay Diagnostics, Inc. (BJDX) - Stock Titan
Bluejay Diagnostics, Inc. (BJDX) stock price, news, quote and history - Yahoo Finance UK
Bluejay Diagnostics, Inc. (BJDX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bank of America details Bluejay Diagnostics, Inc. (BJDX) insider stake - Stock Titan
Bluejay completes 750-patient sepsis study - grafa.com
Bluejay Diagnostics Completes Enrollment in SYMON-II Clinical Validation Study - marketscreener.com
Bluejay Diagnostics Announces Successful Completion Of Enrollment In The Symon-II Multicenter Clinical Validation Study - TradingView
Bluejay completes enrollment in sepsis diagnostic study By Investing.com - Investing.com South Africa
Bluejay completes enrollment in sepsis diagnostic study - Investing.com
Bluejay Diagnostics Completes Enrollment in SYMON-II Sepsis Validation Study Ahead of Schedule - Quiver Quantitative
Bluejay's sepsis study enrolls 750 patients ahead of schedule - Stock Titan
What's going on with Bluejay Diagnostics shares on Wednesday? - MSN
HRT FINANCIAL LP Acquires 92,055 Shares in Bluejay Diagnostics I - GuruFocus
BJDX Stock Pulls Back As Volatility Cools And Cash Runway Stands Out - StocksToTrade
BJDX Stock Crafts Tight Range After Big Spike - StocksToTrade
BJDX Stock Pulls Back As Traders Watch Key Support - timothysykes.com
Insider Sell: Financial Hrt Sells Shares of Bluejay Diagnostics Inc (BJDX) - GuruFocus
Form 4 Bluejay Diagnostics Inc For: 13 July By Investing.com - Investing.com Canada
HRT Financial LP sells $48,913 in Bluejay Diagnostics stock - Investing.com
HRT Financial LP sells $48,913 in Bluejay Diagnostics stock By Investing.com - Investing.com Nigeria
Bluejay Diagnostics (NASDAQ: BJDX) holder HRT Financial reports net share buying and selling - Stock Titan
[Form 3] Bluejay Diagnostics, Inc. Initial Statement of Beneficial Ownership - Stock Titan
BJDX Q4 2023 Earnings: Wide EPS Miss and No Revenue, Yet Stock Gains 3.57%Margin Expansion Trends - dars.gov.et
Form 4 Bluejay Diagnostics Inc For: 10 July By Investing.com - Investing.com Nigeria
Bluejay Diagnostics (NASDAQ: BJDX) shows Bank of America entities as 10% owners - Stock Titan
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) sees 8 shares reported by Bank of America - Stock Titan
Bluejay Diagnostics Inc. (BJDX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
BJDX Stock Pulls Back As Traders Eye Cash Runway - StocksToTrade
BJDX Stock Slides As Traders Gauge Cash Runway And Volatility - timothysykes.com
BJDX Stock Pulls Back As Traders Eye Support Levels - StocksToTrade
BJDX Stock Slides As Traders Study Volatile Chart - timothysykes.com
BJDX Stock Slides As Traders Focus On Cash Runway And Volatility - StocksToTrade
Bluejay Diagnostics stock rally meets a June warrant wall after pre-market churn - TechStock²
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
BJDX Stock Slides As Traders Watch Support Levels - timothysykes.com
BJDX Q4 2023 Earnings: EPS Misses Estimates; No Revenue Reported, Stock DeclinesEarnings Season Preview - dars.gov.et
Bluejay Diagnostics Advances Symphony IL-6 Sepsis Pilot, Keeping Investor Focus on ER Diagnostics - TipRanks
Market Movers | Winners: TRNR, DCOY, ATLN | Losers: BJDX, EVMN, CELZ - Trefis
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Bluejay Diagnostics, Inc. SEC Filing (Jun 29, 2026) - Stock Titan
Bluejay Diagnostics Inc Stock (BJDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
4.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):